Total Payments
$747.30
2024 Payments
$231.49
Companies
8
Transactions
19
Medicare Patients
1,699
Medicare Billing
$200,487
Payment Breakdown by Category
Food & Beverage$747.30 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $747.30 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $179.15 | 4 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $136.19 | 7 | $0 (2023) |
| Allergan Inc. | $122.67 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $121.82 | 1 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $109.67 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $31.78 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $29.08 | 2 | $0 (2021) |
| ABBVIE INC. | $16.94 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $231.49 | 2 | GlaxoSmithKline, LLC. ($121.82) |
| 2023 | $114.86 | 6 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($83.08) |
| 2022 | $70.05 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($53.11) |
| 2021 | $66.74 | 3 | PFIZER INC. ($51.41) |
| 2020 | $32.80 | 2 | PFIZER INC. ($19.05) |
| 2018 | $122.67 | 1 | Allergan Inc. ($122.67) |
| 2017 | $108.69 | 1 | PFIZER INC. ($108.69) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $109.67 | General |
| Category: Nephrology | ||||||
| 11/08/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/04/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/30/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/24/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/14/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/12/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/07/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/16/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.59 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/06/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/05/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.12 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/25/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/22/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $122.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/24/2017 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $108.69 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 167 | 238 | $56,450 | $18,314 |
| 2022 | 6 | 361 | 580 | $126,266 | $42,194 |
| 2021 | 10 | 543 | 879 | $195,393 | $64,177 |
| 2020 | 12 | 628 | 985 | $232,126 | $75,802 |
Total Patients
1,699
Total Services
2,682
Medicare Billing
$200,487
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 102 | $18,606 | $6,173 | 33.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 53 | $16,430 | $5,131 | 31.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 33 | $8,659 | $3,083 | 35.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 37 | 37 | $6,788 | $2,198 | 32.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $5,967 | $1,728 | 29.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 178 | $42,008 | $13,916 | 33.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 107 | 220 | $36,300 | $12,136 | 33.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 42 | $19,278 | $6,502 | 33.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 96 | 102 | $16,932 | $5,666 | 33.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $6,820 | $2,323 | 34.1% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $4,928 | $1,652 | 33.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 161 | 371 | $61,215 | $20,644 | 33.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 96 | 183 | $43,188 | $14,752 | 34.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 126 | 128 | $21,248 | $7,078 | 33.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 15 | 39 | $26,013 | $6,837 | 26.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 40 | 41 | $18,819 | $6,445 | 34.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 35 | $10,850 | $3,743 | 34.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 31 | 31 | $5,146 | $1,686 | 32.8% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 14 | 14 | $4,312 | $1,479 | 34.3% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 13 | 17 | $2,822 | $959.48 | 34.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 20 | $1,780 | $552.84 | 31.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 164 | 381 | $64,699 | $21,652 | 33.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 99 | 207 | $49,886 | $17,225 | 34.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 58 | 61 | $29,393 | $9,505 | 32.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 107 | 110 | $18,398 | $6,193 | 33.7% |
About Dr. Ankush Asija, MD
Dr. Ankush Asija, MD is a Hospitalist healthcare provider based in Puyallup, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2013. The National Provider Identifier (NPI) number assigned to this provider is 1952742298.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankush Asija, MD has received a total of $747.30 in payments from pharmaceutical and medical device companies, with $231.49 received in 2024. These payments were reported across 19 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($747.30).
As a Medicare-enrolled provider, Asija has provided services to 1,699 Medicare beneficiaries, totaling 2,682 services with total Medicare billing of $200,487. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Nephrology
- Location Puyallup, WA
- Active Since 07/16/2013
- Last Updated 08/14/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1952742298
Products in Payments
- LifeVest (Device) $136.19
- AVYCAZ (Drug) $122.67
- BENLYSTA (Biological) $121.82
- TARPEYO (Drug) $109.67
- XELJANZ (Drug) $108.69
- ELIQUIS (Drug) $70.46
- DIFICID (Drug) $31.78
- XARELTO (Drug) $29.08
- DALVANCE (Drug) $16.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.